Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect - PubMed (original) (raw)

Review

Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect

Marina Miguel-Álvarez et al. Drugs Aging. 2015 Feb.

Abstract

Introduction: Alzheimer's disease (AD) is the cause of more than two-thirds of all dementia cases. Although there is no effective treatment against this disorder, its association with neuroinflammation suggests that non-steroidal anti-inflammatory drugs (NSAIDs) might represent a potential therapeutic option.

Objective: The objective of this study was to evaluate the efficacy of NSAIDs in the treatment of AD using a meta-analysis approach.

Methods: MEDLINE, Web of Science, Science Direct, and the Cochrane Library were used to search all the randomized controlled trials that have evaluated the efficacy of NSAIDs as a treatment for AD (up to 1 October 2014). The overall effect of NSAIDs versus placebo was determined using a random effects model meta-analysis where we compared changes (i.e., mean differences pre- vs. post-treatment) between the two conditions in test scores indicative of cognition, disease severity, and related outcomes.

Results: Seven studies were finally included in the meta-analysis. Diclofenac/misoprostol, nimesulide, naproxen, rofecoxib, ibuprofen, indomethacin, tarenflurbil, and celecoxib were the NSAIDs used in these reports. The results of the AD Assessment Scale-cognitive subscale (ADAS-cog), the Clinical Dementia Rating Scale sum-of-boxes (CDR-SOB), and the Mini-Mental State Examination (MMSE) showed no statistical or clinical significance of NSAIDs treatment compared with placebo, i.e., mean differences of -0.24 (95% Confidence Interval (CI) -1.04 to 0.57; P = 0.52), -0.07 (95% CI -0.7 to 0.56; P = 0.82), and 0.35 (95% CI -0.34 to 1.04; P = 0.32), respectively.

Conclusion: Current preliminary evidence suggests no beneficial effect of NSAIDs on cognition or overall AD severity. Thus, although more research is needed in the field, the evidence available does not support the use of NSAIDs for AD treatment.

PubMed Disclaimer

Cited by

Alzheimer's Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease.
Severini C, Barbato C, Di Certo MG, Gabanella F, Petrella C, Di Stadio A, de Vincentiis M, Polimeni A, Ralli M, Greco A. Severini C, et al. Curr Neuropharmacol. 2021;19(4):498-512. doi: 10.2174/1570159X18666200621204546. Curr Neuropharmacol. 2021. PMID: 32564756 Free PMC article. Review.
Potential Use of Agave Genus in Neuroinflammation Management.
Herrera-Ruiz M, Jiménez-Ferrer E, González-Cortazar M, Zamilpa A, Cardoso-Taketa A, Arenas-Ocampo ML, Jiménez-Aparicio AR, Monterrosas-Brisson N. Herrera-Ruiz M, et al. Plants (Basel). 2022 Aug 25;11(17):2208. doi: 10.3390/plants11172208. Plants (Basel). 2022. PMID: 36079590 Free PMC article. Review.
Hallmarks of aging in age-related macular degeneration and age-related neurological disorders: novel insights into common mechanisms and clinical relevance.
Vujosevic S, Limoli C, Kozak I. Vujosevic S, et al. Eye (Lond). 2024 Sep 17. doi: 10.1038/s41433-024-03341-5. Online ahead of print. Eye (Lond). 2024. PMID: 39289517 Review.
Crocetin attenuates inflammation and amyloid-β accumulation in APPsw transgenic mice.
Zhang J, Wang Y, Dong X, Liu J. Zhang J, et al. Immun Ageing. 2018 Oct 30;15:24. doi: 10.1186/s12979-018-0132-9. eCollection 2018. Immun Ageing. 2018. PMID: 30450117 Free PMC article.
New Possibilities in the Therapeutic Approach to Alzheimer's Disease.
Doroszkiewicz J, Mroczko B. Doroszkiewicz J, et al. Int J Mol Sci. 2022 Aug 10;23(16):8902. doi: 10.3390/ijms23168902. Int J Mol Sci. 2022. PMID: 36012193 Free PMC article. Review.

References

1. Neurobiol Aging. 2000 May-Jun;21(3):449-50; discussion 451-3 - PubMed
1. Arch Psychiatr Nurs. 1997 Dec;11(6):295-303 - PubMed
1. Int J Biochem Cell Biol. 2005 Feb;37(2):289-305 - PubMed
1. N Engl J Med. 2001 Nov 22;345(21):1567-8 - PubMed
1. BMC Geriatr. 2005 Jan 12;5:2 - PubMed

Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect - PubMed (original) (raw)